Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Abivertinib |
| Trade Name | |
| Synonyms | Avitinib|AC0010|AC0010MA |
| Drug Descriptions |
Abivertinib (AC0010) is a BTK inhibitor and a third-generation EGFR inhibitor that blocks the activity of mutant forms of EGFR while sparing wild-type EGFR, which potentially results in increased apoptosis and cell cycle arrest, and decreased viability and colony formation, and inhibits tumor growth (PMID: 27573423, PMID: 31310800). |
| DrugClasses | BTK inhibitor 38 EGFR Inhibitor 3rd gen 28 |
| CAS Registry Number | 1557267-42-1 |
| NCIT ID | C147125 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abiraterone + Abivertinib | Abiraterone Abivertinib | 0 | 1 |
| Abivertinib | Abivertinib | 1 | 1 |
| Abivertinib + Omacetaxine mepesuccinate | Abivertinib Omacetaxine mepesuccinate | 1 | 0 |